AASTROM BIOSCIENCES INC
10-Q, EX-27.1, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: AASTROM BIOSCIENCES INC, 10-Q, 2000-11-13
Next: NICHOLS JAMES R, 13F-HR, 2000-11-13



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER
30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       3,764,000
<SECURITIES>                                 7,969,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            12,264,000
<PP&E>                                       3,111,000
<DEPRECIATION>                               2,869,000
<TOTAL-ASSETS>                              12,506,000
<CURRENT-LIABILITIES>                          880,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    92,954,000
<OTHER-SE>                                (81,328,000)
<TOTAL-LIABILITY-AND-EQUITY>                12,506,000
<SALES>                                              0
<TOTAL-REVENUES>                               167,000
<CGS>                                                0
<TOTAL-COSTS>                                1,782,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,406,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,406,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,406,000)
<EPS-BASIC>                                     (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission